{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:21:48Z","timestamp":1788168108208,"version":"build-2803163510"},"reference-count":94,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Monoclonal gammopathy of undetermined significance (MGUS) is commonly encountered in older individuals. MGUS, by definition, is a benign finding where an expanded population of clonal plasma and B-cells produces a monoclonal antibody that is a biologically inactive. Even in patients with overt plasma cell neoplasms such as multiple myeloma, the monoclonal antibody is often a marker of disease burden but not pathogenic except in light chain cast nephropathy. However, there is a growing recognition that, in rare cases, clonal cells and\/or monoclonal gammopathy not meeting criteria for hematologic malignancy can be pathogenic drivers of disease. These MGUS syndromes have been termed monoclonal gammopathies of clinical significance (MGCS), a larger umbrella under which sits the monoclonal gammopathies of renal significance (MGRS). In this review, we focus on MGCS entities beyond standard MGRS and provide a mechanism-based classification centered on the pathogenic nature of the paraprotein rather than on clonal disease burden. We highlight MGCS entities of relevance to nephrologists, including POEMS syndrome, TEMPI syndrome, monoclonal gammopathy-associated systemic capillary leak syndrome, and hematologic autoantibody-mediated disorders. Awareness and recognition of these rare processes are ultimately essential for accurate diagnosis and patient management.<\/jats:p>","DOI":"10.1093\/ndt\/gfag173","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:01:56Z","timestamp":1785585716000},"source":"Crossref","is-referenced-by-count":0,"title":["Monoclonal gammopathy of clinical significance: a guide for nephrologists"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-641X","authenticated-orcid":false,"given":"Patrick","family":"Hofmann","sequence":"first","affiliation":[{"name":"Nephrology Division, Department of Internal Medicine, Mass General Brigham , Boston, MA ,","place":["USA"]},{"name":"Harvard Medical School , Boston, MA ,","place":["USA"]},{"name":"Harvard T.H. Chan School of Public Health , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujal I","family":"Shah","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, MA ,","place":["USA"]},{"name":"Department of Pathology, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut G","family":"Rennke","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, MA ,","place":["USA"]},{"name":"Department of Pathology, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Schwotzer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Sykes","sequence":"additional","affiliation":[{"name":"Center for Hematology, Mass General Brigham Cancer Institute , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-1411","authenticated-orcid":false,"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, and Hematology, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raad B","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Internal Medicine, Mass General Brigham , Boston, MA ,","place":["USA"]},{"name":"Harvard Medical School , Boston, MA ,","place":["USA"]},{"name":"Adult Survivorship Program, Dana-Farber Cancer Institute , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2026083104563348500_bib1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMra2412716","article-title":"Monoclonal gammopathy of undetermined significance","volume":"393","author":"Rajkumar","year":"2025","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib3","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.3324\/haematol.2023.283191","article-title":"Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study","volume":"108","author":"Sigurbergsd\u00f3ttir","year":"2023","journal-title":"Haematologica"},{"key":"2026083104563348500_bib4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1182\/hematology.2020000122","article-title":"Monoclonal gammopathies of clinical significance","volume":"2020","author":"Dispenzieri","year":"2020","journal-title":"Hematology"},{"key":"2026083104563348500_bib5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2026083104563348500_bib6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ndt\/gfaf254","article-title":"Management of monoclonal gammopathy of renal significance: treatment standard","volume":"41","author":"Jaturapisanukul","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026083104563348500_bib7","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"2026083104563348500_bib8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1182\/hematology.2024000572","article-title":"MGCS: where do we stand today?","volume":"2024","author":"Iberri","year":"2024","journal-title":"Hematology"},{"key":"2026083104563348500_bib9","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"key":"2026083104563348500_bib10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"key":"2026083104563348500_bib11","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1182\/blood.V100.5.1817.h81702001817_1817_1827","article-title":"Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature","volume":"100","author":"Lebeau","year":"2002","journal-title":"Blood"},{"key":"2026083104563348500_bib12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1056\/NEJMoa2415930","article-title":"VITT-like monoclonal gammopathy of thrombotic significance","volume":"392","author":"Wang","year":"2025","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00277-016-2650-x","article-title":"Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias","volume":"95","author":"Dicke","year":"2016","journal-title":"Ann Hematol"},{"key":"2026083104563348500_bib14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.critrevonc.2013.02.004","article-title":"Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship","volume":"87","author":"Castelli","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026083104563348500_bib15","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3389\/fimmu.2018.02260","article-title":"Both monoclonal and polyclonal immunoglobulin contingents mediate complement activation in monoclonal gammopathy associated-C3 glomerulopathy","volume":"9","author":"Chauvet","year":"2018","journal-title":"Front Immunol"},{"key":"2026083104563348500_bib16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.kint.2018.01.037","article-title":"C3 glomerulopathy associated with monoclonal Ig is a distinct subtype","volume":"94","author":"Ravindran","year":"2018","journal-title":"Kidney Int"},{"key":"2026083104563348500_bib17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib18","first-page":"sfad306","article-title":"The spectrum of thrombotic microangiopathy related to monoclonal gammopathy","author":"van","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026083104563348500_bib19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J Exp Med"},{"key":"2026083104563348500_bib20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1182\/blood.2019004216","article-title":"The TEMPI syndrome","volume":"135","author":"Sykes","year":"2020","journal-title":"Blood"},{"key":"2026083104563348500_bib21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1182\/hematology.2025000729","article-title":"POEMS syndrome: diagnosis, treatments, and outcomes","volume":"2025","author":"Dispenzieri","year":"2025","journal-title":"Hematology"},{"key":"2026083104563348500_bib22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-024-00571-5","article-title":"Systemic capillary leak syndrome","volume":"10","author":"Druey","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2026083104563348500_bib23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler\u2019s syndrome: diagnosis, treatment, and follow-up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"key":"2026083104563348500_bib24","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1056\/NEJMra2400092","article-title":"Cryoglobulinemia\u2014one name for two diseases","volume":"391","author":"Cacoub","year":"2024","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib25","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/ajh.27081","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"98","author":"Dispenzieri","year":"2023","journal-title":"Am J Hematol"},{"key":"2026083104563348500_bib26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jamaoncol.2021.0586","article-title":"Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome","volume":"7","author":"Khouri","year":"2021","journal-title":"JAMA Oncol"},{"key":"2026083104563348500_bib27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.leukres.2016.09.017","article-title":"Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome","volume":"50","author":"Wang","year":"2016","journal-title":"Leuk Res"},{"key":"2026083104563348500_bib28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archdermatol.2010.100","article-title":"Skin manifestations and vascular endothelial growth factor levels in poems syndrome: impact of autologous hematopoietic stem cell transplantation","volume":"146","author":"Barete","year":"2010","journal-title":"Arch Dermatol"},{"key":"2026083104563348500_bib29","doi-asserted-by":"publisher","first-page":"e70293","DOI":"10.1002\/cncr.70293","article-title":"Long-term outcomes of newly diagnosed POEMS syndrome patients treated with bortezomib-based therapies","volume":"132","author":"He","year":"2026","journal-title":"Cancer"},{"key":"2026083104563348500_bib30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jacc.2006.09.053","article-title":"Vascular endothelial growth factors biology and current status of clinical applications in cardiovascular medicine","volume":"49","author":"Yl\u00e4-Herttuala","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026083104563348500_bib31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor A","volume":"24","author":"P\u00e9rez-Guti\u00e9rrez","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026083104563348500_bib32","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D\u2019Souza","year":"2011","journal-title":"Blood"},{"key":"2026083104563348500_bib33","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/s41375-025-02659-7","article-title":"Interleukin-6 is a highly prognostic biomarker for POEMS syndrome","volume":"39","author":"Cook","year":"2025","journal-title":"Leukemia"},{"key":"2026083104563348500_bib34","doi-asserted-by":"publisher","first-page":"e70065","DOI":"10.1002\/hon.70065","article-title":"Non-clonal lymphoproliferative diseases","volume":"43","author":"Dirnhofer","year":"2025","journal-title":"Hematol Oncol"},{"key":"2026083104563348500_bib35","doi-asserted-by":"publisher","first-page":"e2022007","DOI":"10.4084\/mjhid.2022.007","article-title":"VEGF and IL-6 correlation in POEMS: a potential upcoming marker of active disease and early autologous BMT response","volume":"14","author":"Laurenti","year":"2022","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2026083104563348500_bib36","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/blood.V87.4.1458.bloodjournal8741458","article-title":"Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome","volume":"87","author":"Gherardi","year":"1996","journal-title":"Blood"},{"key":"2026083104563348500_bib37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/ndt\/gfv261","article-title":"Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome","volume":"31","author":"Ye","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2026083104563348500_bib38","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1093\/ndt\/14.10.2370","article-title":"A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome","volume":"14","author":"Nakamoto","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"2026083104563348500_bib39","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","article-title":"The role of vascular endothelial growth factor (VEGF) in renal pathophysiology","volume":"65","author":"Schrijvers","year":"2004","journal-title":"Kidney Int"},{"key":"2026083104563348500_bib40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3109\/10428190009087030","article-title":"Increased expression of vascular endothelial growth factor (VEGF) in Castleman\u2019s Disease: proposed pathomechanism of vascular proliferation in the affected lymph node","volume":"38","author":"Nishi","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"2026083104563348500_bib41","first-page":"27","article-title":"Primarily VEGF-driven etiopathogenesis of Tafro syndrome and fibroblastic reticular cells as a probable castleman cell\u2014qualitative metasynthesis","volume":"136","author":"Lee","year":"2020","journal-title":"Blood"},{"key":"2026083104563348500_bib42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1056\/NEJMc1106670","article-title":"The TEMPI syndrome\u2014a novel multisystem disease","volume":"365","author":"Sykes","year":"2011","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib43","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1007\/s00277-024-05893-8","article-title":"TEMPI syndrome: difficult to diagnose, \u201ceasy\u201d to treat?","volume":"103","author":"Fotiou","year":"2024","journal-title":"Ann Hematol"},{"key":"2026083104563348500_bib44","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMc1804415","article-title":"Complete responses in the TEMPI syndrome after treatment with daratumumab","volume":"378","author":"Sykes","year":"2018","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib45","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1056\/NEJMc2411016","article-title":"Teclistamab as successful treatment of relapsed TEMPI syndrome","volume":"391","author":"Sykes","year":"2024","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/modpathol.2014.117","article-title":"Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist","volume":"28","author":"Rosado","year":"2015","journal-title":"Mod Pathol"},{"key":"2026083104563348500_bib47","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/labmed\/lmad003","article-title":"Comprehensive next-generation sequencing testing in a patient with TEMPI syndrome","volume":"54","author":"Rosado","year":"2023","journal-title":"Lab Med"},{"key":"2026083104563348500_bib48","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1182\/bloodadvances.2020003783","article-title":"Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome","volume":"5","author":"Sun","year":"2021","journal-title":"Blood Adv"},{"key":"2026083104563348500_bib49","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2024b68at6ty","article-title":"A rare cause of AKI in an even rarer syndrome","volume":"35","author":"Freeman","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026083104563348500_bib50","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"2026083104563348500_bib51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2141.1991.tb04428.x","article-title":"Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment","volume":"78","author":"Edmunds","year":"1991","journal-title":"Br J Haematol"},{"key":"2026083104563348500_bib52","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1056\/NEJMc1202649","article-title":"Bortezomib to treat the TEMPI syndrome","volume":"366","author":"Kwok","year":"2012","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib53","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1056\/NEJMc1205806","article-title":"Complete and partial responses of the TEMPI syndrome to bortezomib","volume":"367","author":"Schroyens","year":"2012","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.kint.2016.11.029","article-title":"Capillary leak syndrome: etiologies, pathophysiology, and management","volume":"92","author":"Siddall","year":"2017","journal-title":"Kidney Int"},{"key":"2026083104563348500_bib55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0002-9343(60)90018-8","article-title":"Cyclical edema and shock due to increased capillary permeability","volume":"29","author":"Clarkson","year":"1960","journal-title":"Am J Med"},{"key":"2026083104563348500_bib56","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jaci.2016.10.042","article-title":"Idiopathic systemic capillary leak syndrome (Clarkson disease)","volume":"140","author":"Druey","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026083104563348500_bib57","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S2665-9913(21)00348-9","article-title":"Monoclonal gammopathy of clinical significance: what the rheumatologist needs to know","volume":"4","author":"Marinkovic","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"2026083104563348500_bib58","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1182\/blood-2011-08-375816","article-title":"Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome)","volume":"119","author":"Xie","year":"2012","journal-title":"Blood"},{"key":"2026083104563348500_bib59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2249.1993.tb08195.x","article-title":"The paraproteins in systemic capillary leak syndrome","volume":"93","author":"Zhang","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"2026083104563348500_bib60","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1161\/ATVBAHA.124.321522","article-title":"PARP15 is a susceptibility locus for Clarkson disease (monoclonal gammopathy\u2013associated systemic capillary leak syndrome)","volume":"44","author":"Chan","year":"2024","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"2026083104563348500_bib61","doi-asserted-by":"publisher","first-page":"eadi1394","DOI":"10.1126\/sciadv.adi1394","article-title":"A ligand-independent Tie2-activating antibody reduces vascular leakage in models of Clarkson disease","volume":"9","author":"Ablooglu","year":"2023","journal-title":"Sci Adv"},{"key":"2026083104563348500_bib62","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jaip.2022.07.006","article-title":"Intravenous immunoglobulins tapering and withdrawal in systemic capillary leak syndrome (Clarkson disease)","volume":"10","author":"Moyon","year":"2022","journal-title":"Allergy Clin Immunol Prac"},{"key":"2026083104563348500_bib63","doi-asserted-by":"publisher","first-page":"03000605241301863","DOI":"10.1177\/03000605241301863","article-title":"A case of frequent prerenal acute kidney injury attacks: importance of recognizing systemic capillary leak syndrome: a case report","volume":"52","author":"Miyazawa","year":"2024","journal-title":"J Int Med Res"},{"key":"2026083104563348500_bib64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.amjmed.2014.08.015","article-title":"High-dose intravenous immunoglobulin therapy for systemic capillary leak syndrome (Clarkson disease)","volume":"128","author":"Xie","year":"2015","journal-title":"Am J Med"},{"key":"2026083104563348500_bib65","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1097\/CCM.0b013e31817d7c71","article-title":"High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome","volume":"36","author":"Lambert","year":"2008","journal-title":"Crit Care Med"},{"key":"2026083104563348500_bib66","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1196\/annals.1423.044","article-title":"Intravenous immunoglobulin and cytokines","volume":"1110","author":"Le\u00a0Pottier","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"2026083104563348500_bib67","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/14737175.2022.2057223","article-title":"Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis","volume":"22","author":"Dalakas","year":"2022","journal-title":"Expert Rev Neurother"},{"key":"2026083104563348500_bib68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10456-021-09813-6","article-title":"Refractory systemic capillary leak syndrome treated with bevacizumab: a case report","volume":"25","author":"Wang","year":"2022","journal-title":"Angiogenesis"},{"key":"2026083104563348500_bib69","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ekir.2022.02.014","article-title":"Anticancer drug-induced capillary leak syndrome","volume":"7","author":"Izzedine","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2026083104563348500_bib70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/curroncol32080469","article-title":"Pembrolizumab-induced simultaneous and refractory systemic capillary leak and cytokine release syndromes: a case report","volume":"32","author":"Roberge-Maltais","year":"2025","journal-title":"Curr Oncol"},{"key":"2026083104563348500_bib71","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1182\/blood-2009-11-252072","article-title":"Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study","volume":"115","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"key":"2026083104563348500_bib72","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/bjh.19957","article-title":"Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: results from iStopMM, a prospective population-based screening study","volume":"206","author":"R\u00f6gnvaldsson","year":"2025","journal-title":"Br J Haematol"},{"key":"2026083104563348500_bib73","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/cancers15020480","article-title":"Monoclonal gammopathy of thrombotic significance","volume":"15","author":"Gkalea","year":"2023","journal-title":"Cancers"},{"key":"2026083104563348500_bib74","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"key":"2026083104563348500_bib75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.ajkd.2021.12.014","article-title":"Complement activation and thrombotic microangiopathy associated with monoclonal gammopathy: a National French Case Series","volume":"80","author":"Martins","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2026083104563348500_bib76","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.critrevonc.2007.12.004","article-title":"Acquired factor VIII inhibitors in oncohematology: a systematic review","volume":"66","author":"Franchini","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026083104563348500_bib77","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2215\/CJN.0000000000000047","article-title":"Exploring the role of antithrombin in nephrotic syndrome\u2013associated hypercoagulopathy: a multi-cohort study and meta-analysis","volume":"18","author":"Abdelghani","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026083104563348500_bib78","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.mayocp.2020.06.061","article-title":"Coagulation abnormalities in light chain amyloidosis","volume":"96","author":"Abdallah","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2026083104563348500_bib79","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/13506129.2019.1620724","article-title":"Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality","volume":"26","author":"Sanchis","year":"2019","journal-title":"Amyloid"},{"key":"2026083104563348500_bib80","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemostasis"},{"key":"2026083104563348500_bib81","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/ajh.23558","article-title":"Transferrin-immune complex disease: a potentially overlooked gammopathy mediated by IgM and IgG","volume":"88","author":"Forni","year":"2013","journal-title":"Am J Hematol"},{"key":"2026083104563348500_bib82","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/ajh.70187","article-title":"Iron overload and anemia in transferrin immune complex disease, an overlooked monoclonal gammopathy of clinical significance","volume":"101","author":"Forni","year":"2026","journal-title":"Am J Hematol"},{"key":"2026083104563348500_bib83","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2025.06.006","article-title":"KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)","volume":"109","author":"Group KDIGO (KDIGO) AW","year":"2026","journal-title":"Kidney Int"},{"key":"2026083104563348500_bib84","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(25)02164-6","article-title":"VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies","volume":"407","author":"Groarke","year":"2026","journal-title":"Lancet"},{"key":"2026083104563348500_bib85","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s10067-025-07506-9","article-title":"Kidney involvement in VEXAS syndrome: insights from a rare case of secondary amyloidosis and systematic review of renal biopsy-confirmed reports","volume":"44","author":"\u015etefan","year":"2025","journal-title":"Clin Rheumatol"},{"key":"2026083104563348500_bib86","doi-asserted-by":"publisher","first-page":"1718342","DOI":"10.3389\/fimmu.2025.1718342","article-title":"Classical complement activation in light and heavy chain deposition disease with acquired cutis laxa and bronchiolitis obliterans: a case report of monoclonal gammopathy of clinical significance","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"2026083104563348500_bib87","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jaad.2017.07.039","article-title":"Paraprotein deposits in the skin","volume":"77","author":"Alegr\u00eda-Landa","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2026083104563348500_bib88","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.mayocp.2017.02.016","article-title":"Presentation and outcomes of localized immunoglobulin light chain amyloidosis The Mayo Clinic Experience","volume":"92","author":"Kourelis","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2026083104563348500_bib89","first-page":"182","article-title":"Another devastating complication of the Schnitzler syndrome: AA amyloidosis","volume":"158","author":"Claes","year":"2008","journal-title":"Br J Dermatol"},{"key":"2026083104563348500_bib90","doi-asserted-by":"crossref","first-page":"e14817","DOI":"10.1111\/ijcp.14817","article-title":"AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of \u201cmonoclonal gammopathy of inflammatory significance\u201d?","volume":"75","author":"Terr\u00e9","year":"2021","journal-title":"Int J Clin Pract"},{"key":"2026083104563348500_bib91","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1182\/blood-2023-189950","article-title":"Monoclonal immunoglobulin deposition disease\u2014a review of current and emerging data","volume":"142","author":"Dalmia","year":"2023","journal-title":"Blood"},{"key":"2026083104563348500_bib92","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"key":"2026083104563348500_bib93","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MD.0b013e3182397166","article-title":"Acquired von Willebrand syndrome associated with monoclonal gammopathy","volume":"90","author":"Voisin","year":"2011","journal-title":"Medicine"},{"key":"2026083104563348500_bib94","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy: a case series","volume":"62","author":"Zand","year":"2013","journal-title":"Am J Kidney Dis"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag173\/70470610\/gfag173.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag173\/70470610\/gfag173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:56:42Z","timestamp":1788166602000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfag173\/8750252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":94,"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag173","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"article-number":"gfag173"}}